acquired aplastic anemia
acquired aplastic anemia
Explore linked clinical trials. Standard reference: MONDO:00156102 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Unrelated And Partially Matched Related Donor PSCT w/ T Cell Receptor (TCR) αβ Depletion for Patients With BMF | Bone Marrow Failure Disorders, Congenital Bone Marrow Failure Syndromes, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Hemoglobinuria, Paroxysmal, Infant, Newborn, Diseases, acquired aplastic anemia, anemia, bone marrow disorder, hematologic disorder, hemolytic anemia, myelodysplastic syndrome, paroxysmal nocturnal hemoglobinuria | Active, not recruiting | Not applicable | 2026-06-17 | NCT03047746 | |
| Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT | Bone Marrow Failure, Bone Marrow Failure Disorders, Congenital Bone Marrow Failure Syndromes, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Infant, Newborn, Diseases, Neoplasms by Histologic Type, Nutritional and Metabolic Diseases, acquired aplastic anemia, anemia, bone marrow disorder, hematologic disorder, hemophagocytic syndrome, hereditary disease, immune system disorder, immunodeficiency disease, immunoproliferative disorder, inborn error of immunity, inborn errors of metabolism, inherited hemoglobinopathy, leukemia, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, metabolic disease, myelodysplastic syndrome, myelodysplastic syndrome with excess blasts, myelodysplastic syndrome with single lineage dysplasia, neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-04-15 | NCT06839456 |